Core Laboratories NV (CLB)

NYSE

Currency in USD

18.22

+0.22(+1.22%)

Real-time Data20:23:21

Fair Value

Day's Range

18.08

18.60

52 wk Range

13.82

25.13

CLB Income Statement

Featured here, the Income Statement (earnings report) for Core Laboratories NV, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2014

31/12

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

Total Revenues

668.21

487.27

470.25

489.74

509.79

Total Revenues Growth

-4.66%

-27.08%

-3.49%

+4.14%

+4.1%

Cost Of Revenues

495.58

385.14

367.9

393.66

399.96

Gross Profit

172.63

102.13

102.36

96.08

109.83

Gross Profit Growth

-15.33%

-40.84%

+0.23%

-6.13%

+14.31%

Gross Profit Margin %

25.83%

20.96%

21.77%

19.62%

21.54%

Other Operating Expenses, Total

70.61

52.5

61.06

53.03

53.47

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-15.97%	-25.65%	+16.31%	-13.16%	+0.84%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	46.52	32.53	43.87	37.57	38.89
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	1.49	-0.9	-1.32	-1.71	-1.21

Operating Income

102.02

49.63

41.3

43.05

56.36

Operating Income Growth

-14.88%

-51.36%

-16.79%

+4.25%

+30.91%

EBIT Margin %

15.27%

10.18%

8.78%

8.79%

11.06%

Net Interest Expenses

-14.69

-14.37

-9.15

-11.57

-13.43

Net Interest Expenses Growth

-10.22%

+2.16%

+36.32%

-26.42%

-16.08%

Interest Expense, Total

-14.69

-14.37

-9.15

-11.57

-13.43

Interest And Investment Income

-

-

-

-

-

Other Non Operating Expenses, Total

-1.52

-1.04

0.29

0.07

0.22

EBT, Excl. Unusual Items

85.81

34.22

32.44

31.55

43.15

Gain (Loss) On Sale Of Assets

1.74

1.25

1.44

1.07

0.2

Other Unusual Items, Total

-

-8.71

2.24

0.67

-2.14

EBT, Incl. Unusual Items

81.99

-91.18

36.11

29.95

41.21

EBT, Incl. Unusual Items Growth

-22.13%

-211.2%

+139.6%

-17.05%

+37.58%

EBT, Incl. Unusual Items Margin

12.27%

-18.71%

7.68%

6.12%

8.08%

Income Tax Expense

-12.29

5.9

15.89

10.3

4.19

Net Income to Company

102.12

-97.5

20.22

19.66

37.03

Minority Interest

-0.13

-0.14

-0.49

-0.21

-0.35

Net Income

101.98

-97.64

19.73

19.45

36.68

Net Income Growth

+28.24%

-195.74%

+120.2%

-1.39%

+88.53%

Net Income Margin %

15.26%

-20.04%

4.19%

3.97%

7.19%

Preferred Dividend and Other Adjustments

-

-

-

-

-

Net Income to Common Excl. Extra Items

94.15

-97.21

19.73

19.45

36.68

Basic EPS - Continuing Operations

2.12

-2.19

0.43

0.42

0.79

Basic EPS - Continuing Operations Growth

+17.9%

-202.97%

+119.62%

-2.08%

+87.12%

Diluted EPS - Continuing Operations

2.11

-2.19

0.42

0.42

0.77

Diluted EPS - Continuing Operations Growth

+17.79%

-203.59%

+119.22%

-0.04%

+83.4%

Basic Weighted Average Shares Outstanding

44.36

44.48

46.01

46.33

46.68

Diluted Weighted Average Shares Outstanding

44.65

44.48

46.69

46.81

47.52

Dividend Per Share

2.2

0.28

0.04

0.04

0.04

Dividend Per Share Growth

0%

-87.27%

-85.71%

0%

0%

EBITDA

124.62

70.49

59.81

60.22

72.15

EBITDA Growth

-12.81%

-43.43%

-15.15%

+0.67%

+19.81%

EBITDA Margin %

18.65%

14.47%

12.72%

12.3%

14.15%

EBIT